Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 11-2025 | 08-2025 | 05-2025 | 02-2025 | 11-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 17 | 21 | 31 | 2 | 33 |
| Accounts receivable | 280 | -10 | -27 | -68 | -109 |
| Other Working Capital | 500 | -324 | -344 | 1,032 | -168 |
| Other Operating Activity | -1,781 | -2,330 | -3,244 | -2,464 | -2,482 |
| Operating Cash Flow | $-984 | $-2,642 | $-3,584 | $-1,498 | $-2,726 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | 0 | -25 |
| Purchase Sale Intangibles | -5 | -15 | -19 | -28 | -13 |
| Other Investing Activity | -5 | -143 | 0 | -28 | -13 |
| Investing Cash Flow | $-5 | $-158 | $-19 | $-28 | $-38 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,474 | 0 | 1,689 | 12 | 4,345 |
| Financing Cash Flow | $3,474 | $0 | $1,689 | $12 | $4,345 |
| Exchange Rate Effect | -6 | 11 | 37 | -95 | -3 |
| Beginning Cash Position | 1,802 | 4,592 | 6,469 | 8,078 | 6,500 |
| End Cash Position | 4,281 | 1,802 | 4,592 | 6,469 | 8,078 |
| Net Cash Flow | $2,485 | $-2,800 | $-1,914 | $-1,514 | $1,582 |
| Free Cash Flow | |||||
| Operating Cash Flow | -984 | -2,642 | -3,584 | -1,498 | -2,726 |
| Capital Expenditure | -5 | -15 | -19 | -28 | -38 |
| Free Cash Flow | -989 | -2,657 | -3,603 | -1,526 | -2,764 |